In the second chapter of our whitepaper series, Futureproofing Your Clinical Trials, we explore the transformative potential of decentralizing clinical trials—conducting research closer to participants’ communities and utilizing remote technologies. 

This chapter highlights how decentralization can enhance inclusivity by making clinical research more accessible and equitable. We examine how partnerships with retail chains and using advanced digital tools, such as telehealth and wearable technologies, can help break down barriers, improve recruitment and retention, and expedite the delivery of life-saving treatments.

For Immediate Release

Washington, D.C. – July 1, 2024 — JPA Health, an independent, full-service agency working exclusively in the health sector, today announces the expansion of its leadership team with the strategic appointments of Colleen Carter as Head of Life Sciences and Adam Pawluk as Head of JPA Labs, the agency’s shared services division. These appointments will be effective immediately.

Colleen Carter will lead the rapidly growing Life Sciences division, which covers pharmaceutical, biotech, medical device, diagnostics, medtech, and digital health industries. Adam Pawluk, previously JPA’s Chief Client Officer, will now oversee JPA Labs, including creative, digital, earned media, serious games and research solutions.  

“We are thrilled to have Colleen join the JPA Health network. Her diverse and valuable expertise will greatly benefit our impressive roster of clients,” said Carrie Jones, CEO of JPA Health. “With her more than 20 years of client-focused global expertise spanning the pharma, diagnostics, device, biotech, and wellness industries, Colleen is a perfect fit for our agency and an invaluable asset as we continue expanding our capabilities globally.”

Colleen most recently worked at Fingerpaint Group, where she served as its first Chief Marketing Officer. In just four years, she supported the evaluation, onboarding, and integration of 10 acquisitions, including targets in medical education, managed care, multicultural, branding and promotion, and global companies. Her commercialization proficiency encompasses more than 50 product and corporate launches, showcasing her ability to create highly effective and successful structures and processes across diverse environments. Colleen’s experience spans across clinical stage milestones, supporting medical affairs and commercial marketing, continuing through product launch and loss of exclusivity. Prior to Fingerpaint, Colleen held senior leadership roles at Concentric Health Experience and Harrison & Star. 

Based in JPA Health’s New York office, Colleen will join JPA’s Executive Leadership Team with responsibility for the Life Sciences P&L. She will report directly to Carrie Jones.

“This is an incredible opportunity to join this dynamic and innovative agency. I am excited to begin this journey alongside Carrie and the amazing teams that make up the Life Sciences division,” said Colleen Carter. “In addition to being one of the best in the business, JPA Health reflects my passion and commitment to making a meaningful impact, driven by a genuine desire to serve others and help solve big problems that truly make the world a healthier place.” 

Adam Pawluk, who has been with JPA Health for seven years, will transition from his role as Chief Client Officer to Head of JPA Labs. Adam has been instrumental in serving JPA’s clients and has significantly contributed to the agency’s specialist model. Based in JPA Health’s Washington, DC office, Adam will continue to serve on the Executive Leadership Team, reporting directly to Carrie Jones.

“I am thrilled to lead JPA Labs as we double-down on our mission to be the leading health innovation agency,” said Adam Pawluk. “Our team of synced-up specialists represents the best talent in the industry, working together seamlessly across creative, digital, data sciences and research solutions to produce game-changing, award-winning work. Our integrated approach is unlike that of any other agency, allowing us to flex and adapt to the needs of each client, ensuring we drive exceptional value and results.” 

This has been an active year for JPA Health, including the recent acquisition of BioCentric, Inc., a medical communications agency with offices in greater Philadelphia and Lausanne, Switzerland, and True North Solutions, a Cambridge, Mass-based consultancy specializing in AI and Machine Learning. With the integration of these two leading agencies, JPA Health continues to build on its mission to provide comprehensive, data-driven, and high-impact services to clients across the Life Sciences, Public Health, One Health, and Federal Government sectors.

JPA Health 
JPA Health is an award-winning independent, full-service agency established in 2007. With offices across the U.S. and Europe, the agency seamlessly brings together flexible solutions in public relations, commercial marketing, patient advocacy, and medical communications across the health sector. Leveraging tailored AI solutions, JPA Health crafts seamless, 360-degree omnichannel strategies to engage healthcare stakeholders effectively. As a women-owned and independent agency, we are passionate about helping people live healthier lives and dedicated to pushing the boundaries of healthcare communications. Discover more at www.jpa.com. 

# # # 

Media Contact: 
Guillermo Meneses, JPA Health
gmeneses@jpa.com 
(202) 445-1570  

With Thanksgiving upon us, JPA principal Carrie Jones extends thanks and gratitude to our inspiring clients and to our incredible team for a year filled with growth. This year, JPA received the “triple crown of accolades,” including:

• PR Week’s Outstanding Small Agency of the Year
• MM+M Midsize Healthcare Agency of the Year
• Modern Healthcare Agency of the Year

It has been a big year for JPA and we could not have achieved all this without our team and our clients. Here’s to an exciting year ahead and the opportunity to continue doing meaningful work across public health and life sciences!

WASHINGTON, D.C., October 25, 2021 – JPA Health, a full-service, independent marketing and communications agency, announced today the addition of Kelly McNeil to its Boston office as a senior vice president (SVP). McNeil brings over 20 years of health marketing experience leading award-winning interdisciplinary teams across the life sciences, pharmaceutical, wellness and medical device sectors, among others.

In her role at JPA Health, McNeil will be leading the firm’s brand marketing efforts for the Life Science practice and supporting the firm’s growth across the biotechnology, pharmaceutical, medical devices, and health tech and diagnostics sectors.

“Boston continues to be an essential market for health innovation and our award-winning unbranded disease education and brand creative campaigns are driving rapid growth for the firm,” said Carrie Jones, principal of JPA Health. “Kelly will deliver enormous value to our clients and team with her marketing acumen, including broad experience launching new and expanding existing brands across the life sciences sector. We are thrilled to welcome her to the team.”

Prior to joining JPA, McNeil worked at precisioneffect, MERGE|Boston and Copernicus, leading large-scale AOR relationships and launch and expansion marketing initiatives for such organizations as Alnylam, Takeda, Biogen, Pfizer, UCB and Boston Scientific. In addition to her agency roles, she is a founding partner of Kindling: A Strategic Marketing Think Tank, an incubator of strategy, marketing and business development services for entrepreneurial ventures, and also a founding partner of In the Bag/Cry for Dawn Productions, an entertainment event production and public relations company.

“In the current healthcare climate, having a robust, insightful and carefully crafted marketing strategy is more important than ever before to build genuine credibility and authentic connections with medical professionals and patients,” said McNeil. “I am very excited to join this remarkable team at JPA and further expand the agency’s brand creative, digital marketing and advertising capability.”

About JPA Health
JPA Health is an award-winning independent, full-service agency established in 2007. With offices in the U.S. and UK, the agency provides marketing, public relations and advocacy services. JPA Health recently was awarded MM&M Midsize Healthcare Agency of the Year, 2021. The firm is a leader in the health sector for its award-winning work designing health campaigns that drive change and deliver measurable results. The JPA Health team is passionate about helping people live healthier lives. Learn more at jpa.com.